Ioannis Skaribas, MD
Interventional Pain Medicine · Houston, TXNPI 1922150945
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (34.1%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Abbott at 52.6% of the total. 2025 is the largest year on record at $34,882, 3.7 times the $9,547 reported in 2019. Among interventional pain medicine clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,340 payments — averaging $68.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$48K
- Nalu Medical, Inc.$28K
- Eminent Spine, LLC$6K
- Painteq LLC$6K
- Nevro Corp.$2K
- Medtronic$718
- plus $892 from 14 others
Across 280 payments — averaging $3166.16 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Averitas Pharma Inc.$325K
- Vertex$222K
- Nevro Corp.$157K
- Abbott$131K
- Globus Medical$25K
- GRT US Holding, Inc.$17K
- plus $9K from 1 others
What the payments were for
- Consulting fees$31,39534%
- Speaking & faculty fees$11,39312%
- Travel & lodging$19,53321%
- Food & beverage$22,97625%
- Education$6,8527%
- Entertainment$250%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 1,131 | $48,496 |
| Nalu Medical, Inc. | 97 | $27,694 |
| Eminent Spine, LLC | 2 | $6,317 |
| Painteq LLC | 5 | $6,197 |
| Nevro Corp. | 53 | $1,861 |
| Medtronic(2 entities) | 15 | $718 |
| Si-bone, Inc. | 4 | $231 |
| Vertiflex, Inc. | 15 | $196 |
| SPR Therapeutics, Inc | 2 | $105 |
| Boston Scientific | 4 | $84 |
| Vertos Medical, Inc. | 2 | $42 |
| Scilex Pharmaceuticals Inc. | 2 | $37 |
| Stimwave Technologies Incorporated | 1 | $35 |
| Globus Medical | 1 | $34 |
| Saluda Medical Americas, Inc. | 1 | $30 |
| Flowonix Medical Incorporated | 1 | $25 |
| Pacira Pharmaceuticals Incorporated | 1 | $24 |
| Elutia, Inc. | 1 | $18 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $17 |
| GRT US Holding, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Nalu Neurostimulation System$26,545
- PROCLAIM$20,777
- Neuromodulation Dspsbls and Accs$7,330
- PAINTEQ$6,075
- Eminent Spine SI Screw System$5,000
- Proclaim IPG$3,826
- Proclaim DRG IPG$3,630
- Prodigy Family of SCS IPGs$669
- Senza$643
- Proclaim Family of SCS IPGs$478
- ETERNA$246
- V-LOC 180$152
- INTELLIS ADAPTIVESTIM$150
- PRODIGY$140
- Senza Spinal Cord Stimulation System$130
- OCTRODE$127
- AUTOFILL$121
- Eon Family of SCS IPGs$120
- Omnia$116
- iFuse Implant$110
How this compares
$92,174 in reported general payments places this provider in the 95th percentile of 287 interventional pain medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 632 | $10,075 |
| Oxymorphone Hcl ErOxymorphone Hcl | 12 | $4,615 |
| Cephalexin | 155 | $1,152 |
| Gabapentin | 106 | $1,065 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 50 | $950 |
| Butalb-Acetaminoph-Caff-CodeinButalbit/Acetamin/Caff/Codeine | 11 | $647 |
| Celecoxib | 42 | $606 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 40 | $518 |
| Pregabalin | 86 | $515 |
| Hydromorphone Hcl | 38 | $495 |
| Tramadol Hcl | 90 | $442 |
| Buprenorphine Hcl | 12 | $420 |
| Morphine Sulfate ErMorphine Sulfate | 26 | $385 |
| Duloxetine Hcl | 31 | $260 |
| Tizanidine Hcl | 19 | $248 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Houston
- Brian BruelHouston$219K
- George AtallahHouston$48K
- Shervin HarandiHouston$39K
- Gabor RaczLubbock$3M
- Pankaj MehtaKilleen$2.1M
- Chad StephensSouthlake$1M
- Ankur KhoslaShenandoah$277K
- Brian RichDecatur$245K
- Bolkar SahinlerLubbock$188K
- Timothy RatinoFort Worth$139K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.